Home Cart 0 Sign in  
X

[ CAS No. 42518-98-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 42518-98-9
Chemical Structure| 42518-98-9
Chemical Structure| 42518-98-9
Structure of 42518-98-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 42518-98-9 ]

Related Doc. of [ 42518-98-9 ]

Alternatived Products of [ 42518-98-9 ]

Product Details of [ 42518-98-9 ]

CAS No. :42518-98-9 MDL No. :MFCD00043886
Formula : C5H2Cl2OS Boiling Point : -
Linear Structure Formula :- InChI Key :BMPDCQVRKDNUAP-UHFFFAOYSA-N
M.W : 181.04 Pubchem ID :589223
Synonyms :

Calculated chemistry of [ 42518-98-9 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 39.51
TPSA : 45.31 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.98 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.91
Log Po/w (XLOGP3) : 3.41
Log Po/w (WLOGP) : 2.78
Log Po/w (MLOGP) : 1.64
Log Po/w (SILICOS-IT) : 3.7
Consensus Log Po/w : 2.69

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.46
Solubility : 0.0634 mg/ml ; 0.00035 mol/l
Class : Soluble
Log S (Ali) : -4.04
Solubility : 0.0165 mg/ml ; 0.0000909 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -2.85
Solubility : 0.258 mg/ml ; 0.00143 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.35

Safety of [ 42518-98-9 ]

Signal Word:Danger Class:8
Precautionary Statements:P260-P261-P264-P270-P271-P280-P301+P312-P301+P330+P331-P302+P352-P303+P361+P353-P304+P340-P305+P351+P338-P310-P312-P321-P322-P330-P363-P405-P501 UN#:3265
Hazard Statements:H302-H312-H314-H332 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 42518-98-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 42518-98-9 ]

[ 42518-98-9 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 6310-09-4 ]
  • [ 42518-98-9 ]
YieldReaction ConditionsOperation in experiment
80%
Stage #1: With pyridine; disulfur dichloride In chlorobenzene at 20℃; for 2 h;
Stage #2: With sulfuryl dichloride In chlorobenzene at 20 - 132℃; for 15.5 h;
To a mixture of 2-acetyl-5-chlorothiophene (0.161 mg, 1.0 mmol), pyridine (0.012 ml, 0.15 mmol), and chlorobenzene (0.35 ml) was added S2CI2 (0.16 ml, 2.0 mmol) while stirring at room temperature. After 2 h SO2CI2 (0.121 ml, 1.5 mmol) was added dropwise, and the resulting mixture was stirred at room temperature for 0.5 h. The mixture was then stirred at 132 °C for 15 h. The mixture was diluted with CDCI3 (2 ml), an internal standard was added (1BU3PO4, 0.0552 ml, 0.20 mmol), and the mixture was analyzed. 1H NMR indicated that 5-chloro-2-thiophene carbonyl chloride had been formed in 80percent yield. 1H NMR (PhCl, CDCI3, 400 MHz) delta = 7.99 (d, J = 4 Hz, 1H), 6.86 (d, J = 4 Hz, 1H).
76% at 70 - 137℃; for 17.75 h; A mixture of 2-acetyl-5-chlorothiophene (161 mg, 1.00 mmol), pyridine (0.008 ml, 0.10 mmol), and thionyl chloride (0.435 ml, 6.00 mmol) was stirred at 70°C for 3 h 15 min, and then at 137°C for 14.5 h. Then the mixture was diluted with CDCI3 (2 ml), an internal standard was added (1BU3PO4, 0.0552 ml, 0.20 mmol), and the mixture was analyzed with 1H NMR: 5-chloro-2-thiophene carbonyl chloride (76percent yield). 1H NMR (CDCI3, 400 MHz) delta = 7.80 (d, J = 4 Hz, 1H), 7.06 (d, J = 4 Hz, 1H). 13C NMR (CDC13, 100 MHz) delta = 158.5, 143.1, 137.5, 134.9, 128.3.
68 %Spectr. at 137℃; for 20 h; A mixture of 2-acetyl-5-chloro-thiophene (0.163 g, 1.0 mmol), pyridine (0.008 ml, 0.1 mmol),and disulfur dichloride (0.240 ml, 3.0 mmol) was stirred at 137 °C for 20 h. The mixture wasdiluted with CDC13 (2 ml), an internal standard was added (iBu3PO4, 0.0552 ml, 0.20 mmol),and the mixture was analyzed. 1H NMR indicated that 5-chloro-2-thiophene carbonyl chloride(68percent yield) had been formed.1H NMR (CDC13, 400 MHz) delta = 7.80 (d, J = 4 Hz, 1H), 7.06 (d, J = 4 Hz, 1H).13C NMR (CDC13, 100 MHz) delta = 158.5, 143.1, 137.5, 134.9, 128.3.
Reference: [1] Patent: WO2017/5606, 2017, A1, . Location in patent: Page/Page column 33
[2] Patent: WO2016/150937, 2016, A1, . Location in patent: Page/Page column 27
[3] Recueil des Travaux Chimiques des Pays-Bas, 1950, vol. 69, p. 1083,1103
[4] Journal of Organic Chemistry, 2015, vol. 80, # 20, p. 10370 - 10374
[5] Patent: WO2016/202757, 2016, A1, . Location in patent: Page/Page column 30
  • 2
  • [ 24065-33-6 ]
  • [ 42518-98-9 ]
YieldReaction ConditionsOperation in experiment
100% With thionyl chloride In dichloromethane for 16 h; Heating / reflux 32.0 g (0.20 mmol) 5-chloro-thiophene-2-carboxylic acid are 150 ml dichloromethane refluxed for 16 h with stirring with 100 ml of thionyl chloride and 250 μl DMF. The reaction mixture is evaporated down i. vac., the residue in each case is mixed 5 times with toluene and twice with dichloromethane and evaporated down completely. The residue is further reacted directly without any further purification.Yield: quant.C5H2Cl2OS (181.04)
100% With oxalyl dichloride In dichloromethane for 16 h; Reflux Intermediate 11A; 5-Chlorothiophene-2-carbonyl chloride 480 mg (2.95 mmol) of 5-chlorothiophene-2-carboxylic acid are dissolved in 24 ml of dichloromethane, and 2.4 ml (27.5 mmol) of oxalyl chloride are added. The mixture is heated under reflux for 16 h. It is then concentrated in vacuo, and the residue is again mixed with dichloromethane and concentrated once again. A viscous oil remains and is dried under high vacuum. 534 mg (quant.) of the target compound are obtained and are reacted further without further purification and characterization.
96.3% With bis(trichloromethyl) carbonate; N,N-dimethyl-formamide In toluene at 80℃; for 0.0147222 h; Inert atmosphere; Green chemistry (1) Passing the material through each module of the microchannel reactor system (including preheating module, reaction module and cooling module) replace the air with nitrogen;
(2) 80 g of 5-chloro-2-formic acid thiophene and 40 g of DMF were added to 1,000 ml of toluene, stirring to dissolved material 1; 60 g of triphosgene was added to 600 ml of toluene as the material 2,
(3) Control material 1 flow rate of 18ml / min; control material 2 flow rate of 10ml / min; the reaction temperature was 80 deg. C, the molar ratio of material 1 to material 2 is 1: 0.35; the residence time of reaction is 53s, the temperature of cooling module is 25 deg. C;
(4) when the reactor material to reach a steady state of each share, collecting the reaction liquid flowing out from the outlet of the reactor, to allow access to material 1 for 50 min (i.e. 900 ml, 70 g of 5-chloro-2-formic acid thiophene) the corresponding reaction solution is, for example, distillation of the solvent by toluene under reduced pressure gave 75.1 g of 5-chloro-2-formylchlorothiophene, yield 96.3percent.
95% With thionyl chloride; N,N-dimethyl-formamide In toluene at 5 - 80℃; for 5 h; In a suitable reactor (for example 250 ml three-necked bottle) in 100 ml toluene, 30g5 - chloro -2 - carboxylic acid thiophene, a catalytic amount of N, N - dimethyl formamide, stirring under cooling to 5 °C following, slowly dropping 30g thionyl chloride, temperature control _AOMARKENCODELTX0AO _ 30 °C. Then completing, system heating to 80 °C, thermal insulation reaction 5.0h, TLC tracking after the reaction is complete, lowering the temperature to 50 - 60 °C, concentrated under reduced pressure, the concentrated residue by vacuum distillation, collecting 82 - 85 °C/4 - 5mmHg distill share 34g colorless transparent liquid, yield: 95percent, GC purity: _AOMARKENCODEGTX0AO _ 99.6percent, single hetero _AOMARKENCODELTX0AO _ 0.15percent.
89.78% With thionyl chloride In toluene at 70 - 105℃; 5-Chlorothiophene-2-carboxylic acid (500 g) was added to toluene (2500 mL) andthe reaction mixture was heated to 70°C to 80°C. Thionyl chloride (275 mL) was added to the reaction mixture over 90 minutes, and the reaction mixture was stirred for 1 hour at 70°C to 80°C. The reaction mixture was heated at 100°C to 105°C for 4 hours to S hours. The reaction mixture was cooled to 60°C to 65°C, and the solvent was completely recovered at 60°C to 65°C under vacuum to obtain 5-chlorothiophene-2-carbonylchloride.Yield: 89.78percent
87% With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃; for 15 h; 137 ml (1.57 mol) of oxalyl dichloride are added to a suspension of 51.2 g (0.315 mmol) of 5-chlorothiophene-2-carboxylic acid in 307 ml of dichloromethane.
After addition of 2 drops of DMF, the mixture is stirred at room temperature for 15 hours.
The solvent and excess oxalyl chloride are then removed on a rotary evaporator.
The residue is distilled under reduced pressure.
The product boils at 74-78° C. and a pressure of 4-5 mbar.
This gives 50.5 g (87percent of theory) of an oil which solidifies on storage in the fridge.
1H-NMR (400 MHz, CDCl3, δ/ppm): 7.79 (d, 1H), 7.03 (d, 1H).
GC/MS (method 9): Rt=5.18 min.
MS (EI+, m/z): 180/182/184 (2 35Cl/37Cl) M+.
87% With oxalyl dichloride In dichloromethane at 20℃; for 15 h; Example 1A
5-Chlorothiophene-2-carbonyl chloride
137 ml (1.57 mol) of oxalyl chloride were added to a suspension of 51.2 g (0.315 mmol) of 5-chlorothiophene-2-carboxylic acid in 307 ml of dichloromethane.
After addition of 2 drops of DMF the mixture was stirred at room temperature for 15 hours.
The solvent and excess oxalyl chloride were then removed on a rotary evaporator.
The residue was distilled under reduced pressure.
The product boiled at 74-78° C. and a pressure of 4-5 mbar.
This gave 50.5 g (87percent of theory) of an oil which solidified on storage in the fridge.
1H-NMR (400 MHz, CDCl3, δ/ppm): 7.79 (d, 1H), 7.03 (d, 1H).
GC/MS (Method 4): Rt=5.18 min.
MS (EI+, m/z): 180/182/184 (235Cl/37Cl) M+.
87% With oxalyl dichloride In dichloromethane at 20℃; for 15 h; Example 1A5-Chlorothiophene-2-carbonyl chloride 137 ml (1.57 mol) of oxalyl chloride were added to a suspension of 51.2 g (0.315 mmol) of 5-chlorothiophene-2-carboxylic acid in 307 ml of dichloromethane. After addition of 2 drops of DMF the mixture was stirred at room temperature for 15 hours. The solvent and excess oxalyl chloride were then removed on a rotary evaporator. The residue was distilled under reduced pressure. The product boiled at 74-78° C. and a pressure of 4-5 mbar. This gave 50.5 g (87percent of theory) of an oil which solidified on storage in the fridge.1H-NMR (400 MHz, CDCl3, 6/ppm): 7.79 (d, 1H), 7.03 (d, 1H).GC/MS (Method 4): Rt=5.18 min.MS (EI+, m/z): 180/182/184 (2 35Cl/37Cl) M+.
16.7 g With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane for 1 h; Inert atmosphere; Reflux Oxalyl chloride (14.0 g, 0.11 mol) is added dropwise to a suspension of 5-chloro-thiophene-2-carboxylic acid (5, 15 g, 0.09 mol) and catalytic amounts of N,N-dimethylformamide in 150 ml of dichloromethane. The reaction mixture is stirred for 1 h at room temperature, then heated to reflux for 1 h. After cooling to room temperature, the reaction mixture is evaporated under reduced pressure to deliver the intermediate 5-chloro-thiophene-2-carboxylic acid chloride (16.7 g, 0.09 mol) as residue. This yellow oil was dissolved in 180 ml of dichloromethane and N,O-dimethylamine hydrochloride (9.9 g, 0.10 mol) was added at 5 °C. Subsequently triethylamine (20.5 g, 0.20 mol) was added dropwise at 5 °C. The resulting thick yellow suspension was diluted with 80 ml of dichloromethane and stirred for 16 h at room temperature. It was washed with water, the organic phase washed with brine, dried over sodium sulfate and concentrated under reduced pressure to give 5-chloro-thiophene-2-carboxylic acid methoxy-methyl-amide (6, 18.8 g, 0.09 mol, 98percent) as a yellow oil. 1H NMR (CDCl3): δ = 3.38 (s, 3H), 3.80 (s, 3H), 6.96 (d, 1H), 7.79 (d, 1H). MS (ESI): m/z = 206 (M), 208 (M+2).
68 g With thionyl chloride In tolueneReflux 62 gm (0.3827 moles) 5-Chloro thiophene-2 -carboxylic acid was charged in 310 ml toluene. To it was charged 67 gm (0.5630 moles) of thionyl chloride at room temperature. The reaction mixture was heated to reflux temperature for about 10- 12 hours. Toluene was distilled out completely to get an oil of 5-chloro thiophene-2 -carbonyl chloride (68 gm).
7.36 g With thionyl chloride In toluene at 105℃; for 8 h; To a solution of 5-chlorothiophene-2-carboxylic acid (VI) (6.51 g, 40 mmol) in toluene,Slowly drop the thionyl chloride(9.52 g, 80 mmol),And then heated to 105 ° C for 8 hours,The reaction solution was cooled to room temperature and dissolved under reduced pressureTo give oily substance 7.36 g of 5-chlorothiophene-2-carboxylic acid chloride (VII) without the need for purification directly for the next step.
2.1 g at 80℃; for 3 h; Add 1.9 g of the compound 5-chlorothiophene-2-carboxylic acid to a 50 mL two-necked flask equipped with a rotor and a thermometer.A drop of pyridine was added, 1.8 g of thionyl chloride was slowly added, and the mixture was heated to 80 ° C with stirring, and the solid was gradually dissolved, and the reaction was kept for 3 hours.After cooling to room temperature, excess thionyl chloride was distilled off under reduced pressure.2.1 g of 5-chlorothiophene-2-carbonyl chloride was obtained as a light yellow oily liquid.

Reference: [1] Patent: US2008/51578, 2008, A1, . Location in patent: Page/Page column 39
[2] Patent: US2011/34453, 2011, A1, . Location in patent: Page/Page column 14
[3] Journal of Labelled Compounds and Radiopharmaceuticals, 2006, vol. 49, # 11, p. 929 - 934
[4] Patent: CN106187993, 2016, A, . Location in patent: Paragraph 0031; 0032; 0033; 0034; 0035; 0036; 0037-0049
[5] Patent: CN106146457, 2016, A, . Location in patent: Paragraph 0074; 0075; 0076
[6] Patent: WO2015/11617, 2015, A1, . Location in patent: Page/Page column 9
[7] Patent: US2010/184767, 2010, A1, . Location in patent: Page/Page column 14
[8] Patent: US2010/273789, 2010, A1, . Location in patent: Page/Page column 9
[9] Patent: US2011/172232, 2011, A1, . Location in patent: Page/Page column 10-11
[10] Chemistry - A European Journal, 2012, vol. 18, # 1, p. 213 - 222
[11] Recueil des Travaux Chimiques des Pays-Bas, 1950, vol. 69, p. 1083,1103
[12] European Journal of Medicinal Chemistry, 1988, vol. 23, p. 477 - 482
[13] Archiv der Pharmazie, 1998, vol. 331, # 12, p. 405 - 411
[14] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 15, p. 1723 - 1727
[15] Patent: US2005/182055, 2005, A1, . Location in patent: Page/Page column 4
[16] Patent: WO2005/68456, 2005, A1, . Location in patent: Page/Page column 8
[17] Patent: WO2005/111029, 2005, A1, . Location in patent: Page/Page column 231-232
[18] Patent: WO2004/60887, 2004, A1, . Location in patent: Page/Page column 8-9
[19] Patent: US2006/142263, 2006, A1, . Location in patent: Page/Page column 61
[20] Patent: WO2006/2099, 2006, A2, . Location in patent: Page/Page column 77
[21] Patent: US2006/183769, 2006, A1, . Location in patent: Page/Page column 62-63
[22] Patent: US5047554, 1991, A,
[23] Patent: US4590203, 1986, A,
[24] Patent: US2007/149522, 2007, A1,
[25] Patent: WO2008/86226, 2008, A2, . Location in patent: Page/Page column 62-63
[26] Patent: US2009/36504, 2009, A1, . Location in patent: Page/Page column 6
[27] Patent: WO2004/83174, 2004, A2, . Location in patent: Page 180
[28] Patent: WO2004/101557, 2004, A1, . Location in patent: Page/Page column 31
[29] Patent: WO2005/111014, 2005, A1, . Location in patent: Page/Page column 135
[30] Patent: US2010/4292, 2010, A1, . Location in patent: Page/Page column 12
[31] Patent: US2010/48548, 2010, A1, . Location in patent: Page/Page column 9
[32] Patent: US2010/216769, 2010, A1, . Location in patent: Page/Page column 19
[33] Patent: WO2006/63113, 2006, A2, . Location in patent: Page/Page column 119-120
[34] Patent: US2008/51578, 2008, A1, . Location in patent: Page/Page column 36
[35] Patent: WO2011/80341, 2011, A1, . Location in patent: Page/Page column 23; 24
[36] Patent: WO2012/35057, 2012, A2, . Location in patent: Page/Page column 6; 28-29
[37] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 9, p. 2803 - 2810
[38] Patent: WO2012/159992, 2012, A1, . Location in patent: Page/Page column 19
[39] Patent: WO2013/53739, 2013, A1, . Location in patent: Page/Page column 34
[40] Patent: WO2013/98833, 2013, A2, . Location in patent: Page/Page column 40
[41] Patent: WO2013/120465, 2013, A1, . Location in patent: Page/Page column 37
[42] Patent: WO2013/46211, 2013, A1, . Location in patent: Page/Page column 48; 49
[43] Patent: WO2013/152168, 2013, A1, . Location in patent: Page/Page column 16-17
[44] Patent: US2013/137730, 2013, A1, . Location in patent: Paragraph 0111-0112
[45] Patent: WO2014/20458, 2014, A1, . Location in patent: Page/Page column 7
[46] Patent: US2014/128601, 2014, A1, . Location in patent: Paragraph 0067
[47] Patent: WO2014/174102, 2014, A1, . Location in patent: Page/Page column 6
[48] Patent: US2014/378682, 2014, A1, . Location in patent: Paragraph 0203; 0217
[49] Patent: WO2015/26761, 2015, A1, . Location in patent: Page/Page column 22
[50] European Journal of Medicinal Chemistry, 2015, vol. 95, p. 388 - 399
[51] Patent: WO2015/198259, 2015, A1, . Location in patent: Page/Page column 7
[52] European Journal of Organic Chemistry, 2016, vol. 2016, # 12, p. 2139 - 2144
[53] Patent: WO2016/30669, 2016, A1, . Location in patent: Page/Page column 29
[54] Molecules, 2016, vol. 21, # 5,
[55] Patent: WO2016/199027, 2016, A1, . Location in patent: Page/Page column 20
[56] Patent: CN105820163, 2016, A, . Location in patent: Paragraph 0140
[57] Patent: CN104016975, 2017, B, . Location in patent: Paragraph 0137-0140
[58] Organic Preparations and Procedures International, 2017, vol. 49, # 2, p. 169 - 177
[59] Patent: CN104592204, 2017, B, . Location in patent: Paragraph 0054; 0057
[60] International Journal of Molecular Sciences, 2017, vol. 18, # 6,
[61] Medicinal Chemistry Research, 2017, vol. 26, # 12, p. 3345 - 3353
[62] Patent: KR2017/98031, 2017, A, . Location in patent: Paragraph 0064-0068; 0085-0087
[63] Patent: EP2314593, 2016, B1, . Location in patent: Paragraph 0050
[64] Patent: US2016/145268, 2016, A1, . Location in patent: Paragraph 0276
[65] Journal of Heterocyclic Chemistry, 2018, vol. 55, # 6, p. 1410 - 1418
[66] Patent: CN104844588, 2018, B, . Location in patent: Paragraph 0030-0031
  • 3
  • [ 96-43-5 ]
  • [ 126-33-0 ]
  • [ 79-37-8 ]
  • [ 42518-98-9 ]
YieldReaction ConditionsOperation in experiment
100% at 165℃; for 17.5 h; A mixture of oxalyl chloride, 2-chlorothiophene and sulfolane (3 : 1: 0.33, molar ratio) was heated in a closed vessel to 165 °C for 17.5 h. Analysis of the reaction mixture by 1H NMR indicated a conversion of 2-chlorothiophene of 100percent and a yield of 5-chlorothiophene-2- carbonyl chloride of 100percent.
Reference: [1] Patent: WO2017/76844, 2017, A1, . Location in patent: Page/Page column 19
  • 4
  • [ 24065-33-6 ]
  • [ 79-37-8 ]
  • [ 42518-98-9 ]
Reference: [1] Patent: US2002/77486, 2002, A1,
[2] Patent: US6906063, 2005, B2,
  • 5
  • [ 96-43-5 ]
  • [ 79-37-8 ]
  • [ 42518-98-9 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1956, vol. <4> 3, p. 137,142
  • 6
  • [ 67-56-1 ]
  • [ 42518-98-9 ]
  • [ 35475-03-7 ]
Reference: [1] Archiv der Pharmazie, 1998, vol. 331, # 12, p. 405 - 411
[2] Patent: WO2006/2099, 2006, A2, . Location in patent: Page/Page column 77
  • 7
  • [ 42518-98-9 ]
  • [ 64-17-5 ]
  • [ 5751-82-6 ]
Reference: [1] Journal of the Chemical Society, 1953, p. 547
  • 8
  • [ 42518-98-9 ]
  • [ 721401-53-2 ]
Reference: [1] Patent: WO2013/156936, 2013, A1,
[2] Patent: WO2015/11617, 2015, A1,
  • 9
  • [ 42518-98-9 ]
  • [ 100-02-7 ]
  • [ 1450877-56-1 ]
Reference: [1] Bulletin of the Korean Chemical Society, 2013, vol. 34, # 7, p. 2036 - 2040
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 42518-98-9 ]

Chlorides

Chemical Structure| 5271-67-0

[ 5271-67-0 ]

2-Thiophenecarbonyl chloride

Similarity: 0.84

Chemical Structure| 7283-96-7

[ 7283-96-7 ]

2-Chloro-5-thiophenecarboxaldehyde

Similarity: 0.82

Chemical Structure| 23784-96-5

[ 23784-96-5 ]

2-Chloro-5-(chloromethyl)thiophene

Similarity: 0.76

Chemical Structure| 67482-49-9

[ 67482-49-9 ]

4,5-Dichlorothiophene-2-carbaldehyde

Similarity: 0.73

Chemical Structure| 6310-09-4

[ 6310-09-4 ]

2-Acetyl-5-chlorothiophene

Similarity: 0.70

Acyl Chlorides

Chemical Structure| 5271-67-0

[ 5271-67-0 ]

2-Thiophenecarbonyl chloride

Similarity: 0.84

Chemical Structure| 39098-97-0

[ 39098-97-0 ]

2-Thiopheneacetyl chloride

Similarity: 0.53